Lyra Therapeutics News

Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(0%),Point72 Capital Advisors, Inc.(0%), etc.

Nov 15 08:52

Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Samsara BioCapital, L.P.(4.98%),Samsara BioCapital GP, LLC(4.98%), etc.

Nov 15 06:51

Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(1.8%),VHCP Co-Investment Holdings II, LLC(1.8%), etc.

Nov 15 06:51

Lyra Therapeutics | SCHEDULE 13G/A: Others

Nov 15 05:58

Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vestal Point Capital, LP(0%),Ryan Wilder(0%)

Nov 15 01:08

Lyra Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 05:30

Lyra Therapeutics | 8-K: Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13 05:25

Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Palasis Maria

Oct 19 04:09

Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cavalier Jason

Oct 19 04:09

Lyra Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(19.5%),Joseph Edelman(19.5%), etc.

Aug 16 06:32

Lyra Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 15 04:29

Lyra Therapeutics | 8-K: Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 15 04:16

Lyra Therapeutics | 8-K: Current report

Jul 24 04:10

Lyra Therapeutics | 8-K: Current report

Jun 19 04:13

Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ALTMAN MICHAEL SETH

Jun 15 04:16

Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Poukalov Konstantin

Jun 15 04:15

Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director TOBIN JAMES R

Jun 15 04:15

Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director snyderman nancy lynn MD

Jun 15 04:15

Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith W Bradford

Jun 15 04:15

Lyra Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MERRIFIELD C ANN

Jun 15 04:15